StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) shareholders

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2024, quý kết thúc ngày Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Ownership

Institutional holdings as of Mar 31, 2025, from 13F filings

Held by institutions
0.0%
0M of 3M shares
Institutional holders
0
0 new, 1 sold out
Net institutional buying
-0M
In Q1 2025
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Steven A. Cohen
Joint filing with Point72 Asset Management, L.P. (9.90%), Point72 Capital Advisors, Inc. (9.90%)
5,793,4529.90%13G (passive)Feb 6, 2024
AIGH Capital Management, LLC
Joint filing with Orin Hirschman (9.90%)
1,247,0619.90%13G (passive) amendmentDec 31, 2023
Albert D. Friedberg
Joint filing with Fcmi Parent Co. (39.30%)
1,039,63139.90%13D (active) amendmentSep 18, 2024
Maurice Zauderer
Joint filing with Vaccinex (Rochester), L.L.C. (16.50%)
472,35716.60%13D (active) amendmentNov 14, 2024

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q1 202500M0.0%0 / 00 / 10M0M
Q4 202410M0.0%0 / 10 / 110M0M
Q3 2024120M12.5%2 / 42 / 10M0M
Q2 2024110M12.0%1 / 24 / 20M0M
Q1 2024120M12.1%12 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Maurice ZaudererPresident and CEO, Director, 10% owner301,54811.27%Nov 18, 2024
Albert FriedbergDirector, 10% owner1,070,38739.99%Nov 18, 2024
Parent Co. FCMI10% owner799,52229.87%Nov 18, 2024
Vaccinex (Rochester), L.L.C.10% owner141,7455.30%Nov 18, 2024

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Albert Friedberg
Director, 10% owner
Nov 14, 2024Award+30,756$3.25$99.96K1,051,389
Maurice Zauderer
President and CEO, Director, 10% owner
Nov 14, 2024Award+46,153$3.25$150.00K297,941
Maurice Zauderer
President and CEO, Director, 10% owner
Sep 18, 2024Option exercise+38,610$5.64$217.76K176,748
Maurice Zauderer
President and CEO, Director, 10% owner
Sep 18, 2024Option exercise+29,557$5.64$166.70K206,305
Maurice Zauderer
President and CEO, Director, 10% owner
Sep 18, 2024Option exercise+9,768$5.64$55.09K216,073
Maurice Zauderer
President and CEO, Director, 10% owner
Sep 18, 2024Option exercise+35,715$5.64$201.43K251,788
Albert Friedberg
Director, 10% owner
Sep 18, 2024Option exercise+25,723$5.64$145.08K1,020,633
Albert Friedberg
Director, 10% owner
Sep 18, 2024Option exercise+214,286$5.64$1.21M994,910
Albert Friedberg
Director, 10% owner
Aug 9, 2024Buy+100$4.51$451780,624
Parent Co. FCMI
10% owner
Aug 6, 2024Buy+2,753$4.92$13.54K780,524
Parent Co. FCMI
10% owner
Aug 5, 2024Buy+3,653$4.60$16.80K777,771
Albert Friedberg
Director, 10% owner
Aug 1, 2024Buy+11,703$4.72$55.24K774,118
Parent Co. FCMI
10% owner
Jul 31, 2024Buy+16,128$7.40$119.35K762,415
Parent Co. FCMI
10% owner
Jul 31, 2024Buy+83,243$6.41$533.59K746,287
Parent Co. FCMI
10% owner
Jul 31, 2024Buy+100,629$5.74$577.61K663,044
Albert Friedberg
Director, 10% owner
May 30, 2024Buy+861$5.20$4.48K562,415
Albert Friedberg
Director, 10% owner
May 29, 2024Buy+957$4.95$4.74K561,554
Van Strydonck, Gerald E.
Director
May 10, 2024Award+543$5.75$3.12K543
Albert Friedberg
Director, 10% owner
Apr 19, 2024Buy+282$4.73$1.33K560,597
Parent Co. FCMI
10% owner
Mar 28, 2024Award+102,960$7.77$800.00K560,315
Vaccinex (Rochester), L.L.C.
10% owner
Mar 28, 2024Award+38,610$7.77$300.00K138,138
Parent Co. FCMI
10% owner
Feb 8, 2024Award+1,655,172$0.73$1.21M6,402,966
Vaccinex (Rochester), L.L.C.
10% owner
Feb 8, 2024Award+413,793$0.73$302.07K1,393,392
Van Strydonck, Gerald E.
Director
Dec 26, 2023Sale−3,149$0.72$2.27K0
Van Strydonck, Gerald E.
Director
Dec 8, 2023Sale−1,334$0.67$8943,149
Maurice Zauderer
President and CEO, Director, 10% owner
Oct 4, 2023Buy+5,000$0.97$4.85K22,116
Maurice Zauderer
President and CEO, Director, 10% owner
Oct 3, 2023Buy+5,000$0.93$4.65K17,116
Maurice Zauderer
President and CEO, Director, 10% owner
Oct 3, 2023Buy+500,000$1.00$500.00K979,599
Albert Friedberg
Director, 10% owner
Oct 3, 2023Buy+3,000,000$1.00$3.00M4,747,794
Maurice Zauderer
President and CEO, Director, 10% owner
Sep 22, 2023Award+2,051,282$0.16$328.21K7,193,973
Albert Friedberg
Director, 10% owner
May 15, 2023Award+6,711,552$0.37$2.48M26,216,904
Maurice Zauderer
President and CEO, Director, 10% owner
Mar 31, 2023Award+731,707$0.41$300.00K5,142,691
Albert Friedberg
Director, 10% owner
Mar 31, 2023Award+4,146,341$0.41$1.70M19,505,352
Maurice Zauderer
President and CEO, Director, 10% owner
Dec 6, 2022Inheritance+3,988––181,736
Albert Friedberg
Director, 10% owner
Nov 23, 2022Award+3,778,575$0.53$2.00M15,359,011
Van Strydonck, Gerald E.
Director
Nov 23, 2022Award+47,232$0.53$25.03K67,232
Jacob B. Frieberg
Director
Nov 23, 2022Award+188,928$0.53$100.13K193,049
Maurice Zauderer
President and CEO, Director, 10% owner
Nov 23, 2022Award+1,511,430$0.53$801.06K4,410,984
Van Strydonck, Gerald E.
Director
Feb 23, 2022Buy+18,000$1.32$23.76K20,000
Van Strydonck, Gerald E.
Director
Feb 23, 2022Buy+2,000$1.30$2.60K2,000
Jacob B. Frieberg
Director
Jan 27, 2022Buy+90,090$1.11$100.00K94,510
Albert Friedberg
Director, 10% owner
Jan 27, 2022Buy+1,801,801$1.11$2.00M3,511,894
Albert Friedberg
Director, 10% owner
Jan 27, 2022Buy+1,801,801$1.11$2.00M11,580,436
Maurice Zauderer
President and CEO, Director
Jan 27, 2022Buy+1,801,801$1.11$2.00M2,899,554
Jacob B. Frieberg
Director
Jun 25, 2021Conversion+4,420––4,420
Jacob B. Frieberg
Director
Jun 25, 2021Conversion+4,121––4,121
Jacob B. Frieberg
Director
Jun 25, 2021Conversion+4,420––57,286
Parent Co. FCMI
10% owner
May 24, 2021Conversion+967,983––967,983
Parent Co. FCMI
10% owner
May 24, 2021Conversion+1,180,051––8,810,652
Scott E. Royer
Chief Financial Officer
Sep 3, 2020Option exercise+500$3.90$1.95K4,499
John E. Leonard
SVP, Development
Jul 27, 2020Option exercise+1,000$3.90$3.90K2,258
John E. Leonard
SVP, Development
Jul 27, 2020Option exercise+1,000$3.90$3.90K1,000
John E. Leonard
SVP, Development
Jul 24, 2020Option exercise+1,258$7.10$8.93K1,258
John E. Leonard
SVP, Development
Jul 14, 2020Option exercise+1,000$3.90$3.90K2,258
Albert Friedberg
Director, 10% owner
Jul 10, 2020Buy+1,126,760$3.55$4.00M1,710,093
Albert Friedberg
Director, 10% owner
Mar 30, 2020Buy+5,000$4.06$20.30K7,630,601
Albert Friedberg
Director, 10% owner
Mar 27, 2020Buy+4,000$4.18$16.72K7,625,601
Albert Friedberg
Director, 10% owner
Mar 26, 2020Buy+1,000$4.44$4.44K7,621,601
Albert Friedberg
Director, 10% owner
Mar 24, 2020Buy+2,000$4.40$8.80K7,620,601
Albert Friedberg
Director, 10% owner
Mar 20, 2020Buy+2,000$4.31$8.62K7,618,601

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
3.2
At 0M shares a day
Change since last report
-23.4%
From 0M shares
Short volume, 20 days
52.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Vaccinex's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?